Back to
Cubist Systematic Strategies, LLC
EGRX25 quarters
Position history for
Cubist Systematic Strategies, LLC's holdings in EAGLE PHARMACEUTICALS INC
No. Cubist Systematic Strategies exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 6,152 shares worth $22,947. Cubist Systematic Strategies already held EGRX in its Q4 2018 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$947,000
Total Shares Change
-23,506
Quarter-by-Quarter History
Other major holders of EGRX: Janus Henderson Group Ltd.